expert roundtables

Advancements in the Management of Chronic Graft-versus-Host Disease
Oncology

Advancements in the Management of Chronic Graft-versus-Host Disease

expert roundtables
By Corey Cutler, MD, MPH, FRCP(C); David Miklos, MD, PhD; Edmund K. Waller, MD, PhD, FACP
Incorporating Novel and Conventional Agents in Chronic Graft-versus-Host Disease
Oncology

Incorporating Novel and Conventional Agents in Chronic Graft-versus-Host Disease

expert roundtables
By Corey Cutler, MD, MPH, FRCP(C); David Miklos, MD, PhD; Edmund K. Waller, MD, PhD, FACP
Therapeutic Sequencing in View of Advanced Prostate Cancer Biology
Oncology

Therapeutic Sequencing in View of Advanced Prostate Cancer Biology

expert roundtables
By Tanya B. Dorff, MD; Neal D. Shore, MD, FACS; Robert Dreicer, MD, MS, MACP, FASCO
High-Risk Prostate Cancer: Implications of Entering a More Molecular, More Genomic Era
Oncology

High-Risk Prostate Cancer: Implications of Entering a More Molecular, More Genomic Era

expert roundtables
By Tanya B. Dorff, MD; Neal D. Shore, MD, FACS; Robert Dreicer, MD, MS, MACP, FASCO
Approach to Patients With Metastatic Gastrointestinal Stromal Tumors Who Are Progressing on Standard Therapy
Oncology

Approach to Patients With Metastatic Gastrointestinal Stromal Tumors Who Are Progressing on Standard Therapy

expert roundtables
By Jonathan C. Trent, MD, PhD; Richard F. Riedel, MD; Suzanne George, MD
Load More